Chargement en cours...
Limited efficacy of pixantrone in refractory diffuse large B-cell lymphoma
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL) is an aggressive disease with poor outcomes in patients ineligible for autologous stem cell transplantation. In this setting, novel treatment approaches are urgently required and the innovative agent pixantrone has shown some promising res...
Enregistré dans:
| Publié dans: | Oncol Lett |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039066/ https://ncbi.nlm.nih.gov/pubmed/32194699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.11288 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|